Publications

CLT-008

References

Arber C, et al. Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted. J Infect Dis 2005; 192(9): 1666-71.

Bitmansour A, et al. Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood 2002; 100(13): 4660-7.

Bitmansour A, et al. Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia. Blood 2005; 105(9): 3535-7.

Cellerant Publications and Presentations

Karsunky H, et al. Production of human myeloid progenitor cells from hematopoietic stem cells for the treatment of neutropenia. Poster presented at: 5th Annual Meeting of the International Society for Stem Cell Research, 2007 Jun 17-20; Cairns, Australia.

Maxey J, et al. Development of a mouse myeloid progenitor cell therapeutic for treatment of HS-ARS in BALB/c mice. Poster presented at: 60th Annual Meeting of the Radiation Research Society, 2014 Sep 21-24; Las Vegas, NV.

Singh VK, et al. Myeloid progenitors: A radiation countermeasure that is effective when initiated days after irradiation. Radiation Research 2012; 177(6): 781-91.

Wieduwilt MJ, et al. Phase 1 clinical investigation of human myeloid progenitor cells (CLT-008) as a supportive care measure after chemotherapy for acute myeloid leukemia (AML). Poster presented at: 56th Annual Meeting of the American Society of Hematology Meeting, 2014 Dec 4-9; San Francisco, CA.

CLT-009

Cellerant Presentation

Chananukul C, et al. Cryopreserved ex vivo expanded human megakaryocyte progenitor cells generated functional platelets after infusion into xenograft animal models. Poster presented at: Gordon Research Conference: Cell Biology of Megakaryocytes & Platelets, 2013 Mar 10-15; Galveston, TX.

CSC012 (Anti-IL1RAP)

References

Barreyro L et al. Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood 2012; 120(6): 1290-98.

Cellerant Presentation

Jiang P, et al. Generation and characterization of antibodies specific for IL-1RAP antigen to target quiescent and proliferating AML leukemic stem cells. Poster presented at: Annual Meeting of the American Association for Cancer Research, 2014 Apr 5-9; San Diego, CA.

 

Copyright ©2006-2016 Cellerant Therapeutics, Inc.